William J. Netzer

Adjunct Investigator

Dr. Netzer’s research focuses on the discovery of molecules and systems within brain cells that can be targeted by drugs to treat Alzheimer’s disease. He discovered that Gleevec, a successful anti-cancer drug, lowers beta-amyloid production which suggests that compounds similar to Gleevec might be useful in the treatment of Alzheimer’s disease.